Skip to main content

Table 3 Variable Response Criteria

From: Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer

Definition of responder Group No Median PFS(95%CI) P Dead No. Median OS(95%CI) P
≥25% Reduction in tumour Nonresponder 100 218(176-259) 0.319 86 335(261-408) 0.240
  Responder 17 289(225-352)   14 377(338-415)  
≥20% Reduction in tumour Nonresponder 82 218(171-264) 0.874 71 323(276-369) 0.168
  Responder 35 270(181-358)   29 412(328-495)  
≥15% Reduction in tumour Nonresponder 66 200(149-250) 0.937 57 323(279-366) 0.323
  Responder 51 242(190-294)   43 385(309-460)  
≥10% Reduction in tumour Nonresponder 54 198(127-268) 0.948 47 320(268-371) 0.334
  Responder 63 225(176-273)   53 387(320-453)  
≥5% Reduction in tumour Nonresponder 46 218(147-289) 0.789 40 320(272-367) 0.362
  Responder 71 221(177-265)   60 385(317-452)  
≥0% Reduction in tumour Nonresponder 17 198(105-291) 0.913 15 323(195-450) 0.448
  Responder 100 221(193-249)   85 350(286-413)  
  1. 95% CI indicates 95% Confidence Interval; PFS Progression-free Survival; OS Overall survival.